Structures by: Cybulski J.
Total: 5
Olanzapine
C17H20N4S
Acta Crystallographica Section E (2004) 60, 1 o66-o68
a=10.388(3)Å b=14.839(4)Å c=10.567(3)Å
α=90.00° β=100.64(3)° γ=90.00°
1-[3-(4-Chlorobenzylideneamino)-2-oxooxazolidin-5-ylmethyl]morpholinium chloride monohydrate
C15H19ClN3O31,Cl1,H2O
Acta Crystallographica Section E (2001) 57, 4 o341-o343
a=7.122(2)Å b=8.809(2)Å c=15.178(3)Å
α=95.98(2)° β=99.34(2)° γ=107.43(2)°
5-morpholinemethyl-3-(4-fluoridebenzylideamin)-2-oxazolidinone chloride monohydrate
C15H19FN3O31,Cl1,H2O
Acta Crystallographica Section E (2001) 57, 5 o469-o471
a=8.9570(9)Å b=27.968(3)Å c=7.1370(10)Å
α=90.00° β=104.820(9)° γ=90.00°
5-morpholinemethyl-3-(4-fluoridebenzylideamin)-2-oxazolidinone
C15H18FN3O3
Acta Crystallographica Section E (2001) 57, 5 o386-o388
a=6.4808(7)Å b=9.9636(9)Å c=12.2753(11)Å
α=91.600(9)° β=101.048(10)° γ=106.114(12)°
Buspirone
C21H31N5O2
Acta Crystallographica Section E (2006) 62, 12 o5616-o5618
a=10.548(2)Å b=11.764(2)Å c=16.998(3)Å
α=90.00° β=99.28(3)° γ=90.00°